ReviewThe Journal of pharmacology and experimental therapeutics2025
Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity.
Ning Kuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.